AB0284 RHEUMATOID ARTHRITIS REFRACTORY TO BIOLOGICAL TREATMENT
نویسندگان
چکیده
منابع مشابه
Rituximab treatment of refractory rheumatoid arthritis.
OBJECTIVE To review published literature using rituximab for treatment of refractory rheumatoid arthritis (RA). DATA SOURCES An English-language literature search was conducted using MEDLINE (1966-May 2005) and EMBASE (1980-May 2005). References of identified articles were subsequently reviewed for additional data. DATA SYNTHESIS Evidence suggests that B lymphocyte depletion in patients suf...
متن کاملTreatment of Rheumatoid Arthritis with Biological Agents
Cytokines and Rheumatoid Arthritis The term “cytokine” is coined from the combination of “cyto”, a prefix which means cell, and “kine”, which denotes movement. Cytokines all have the following features: 1. They are low-molecular-weight glycoproteins that are not hormones. 2. They have an effect at very small concentrations. 3. Different cytokines can have the same function (redundancy). For exa...
متن کاملRheumatoid Arthritis: Early diagnosis and treatment outcomes
Rheumatoid arthritis (RA) is an inflammatory progressive disease which in the absence of appropriate treatment can lead to joint destruction and disability. Prognosis of RA may be predicted based on the presence of some clinical and laboratory evidences.New criteria for classification of RA provides opportunity for earlier treatment. Initiation of treatment particularly by combination of DMARDs...
متن کاملBiological treatment in rheumatoid arthritis: when to stop?
Randomised controlled trials of the eff ect of stopping treatment are rare, but in The Lancet Josef Smolen and colleagues report results showing that it is possible to stop a risky and expensive treatment for many patients with rheumatoid arthritis once an initial response has been obtained. Newly diagnosed adult patients were treated fi rst with either methotrexate plus placebo (n=517) or meth...
متن کاملComparative efficacy of biological agents in methotrexate-refractory rheumatoid arthritis patients: a Bayesian mixed treatment comparison
BACKGROUND/AIMS Biological agents (biologics) targeting proinflammatory signaling have emerged as an important treatment option in rheumatoid arthritis (RA). Despite the clinical effectiveness of biologics for patients with RA who do not respond to 'traditional' disease-modifying anti-rheumatic drugs (DMARDs), there are concerns regarding their cost and long-term safety. In this study, we aimed...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Annals of the Rheumatic Diseases
سال: 2020
ISSN: 0003-4967,1468-2060
DOI: 10.1136/annrheumdis-2020-eular.2954